Toronto, Canada (ots/PRNewswire) -
- Ontario Biotech Companies Work Together on Innovative Bone
TORONTO, Canada, October 28 /PRNewswire/ --
Thomas Wellner, President and CEO of Therapure BioPharma Inc. and
Dr. Cameron Clokie, President and CEO of Induce Biologics Inc. today
announced a development partnership utilizing an innovative approach
to the production and manufacture of selected growth factors for
stimulating bone regeneration. Such growth factors are critical
tools used in regenerative medicine, with particular applications in
the regeneration of the skeleton.
Therapure will apply its experience and knowledge in cell
culture and in the design and development of scaled-up biologic
manufacturing processes to advance the initial research and
development conducted by Induce. The technology is a result of over
10 years of research and development by the founders of Induce in
the areas of bone regeneration and the development of growth factor
containing bone grafts.
"Induce's technology is a tremendous example of the creativity
and innovation that exists in Ontario," said Thomas Wellner. "We are
very pleased that they have chosen Therapure Biopharma as their
partner for the further development of this important new technology
and we look forward to working with them to bring this product to a
"Our technology was invented in Canada", said Cameron Clokie,
"and we are excited to have found a company in Ontario that is
capable of working with us to further develop this technology. We
are pleased that Therapure Biopharma is as eager as we are to make
this technology available to patients world-wide."
About Therapure Biopharma:
Therapure Biopharma Inc. is an integrated biopharmaceutical
company that develops, manufactures, purifies, and packages
therapeutic proteins. Therapure Biopharma acquired its
Canadian-built and conceived facility from Hemosol Corporation, a
specialist in therapies derived from hemoglobin, a blood protein.
Therapure Biopharma applies scientific, manufacturing, and
downstream purification expertise with an intimate understanding of
advanced biology, complex proteins, and regulatory processes to
develop effective and innovative solutions to advance products from
discovery to market.
For more information, please visit: http://www.therapurebio.com
About Induce Biologics Inc.:
Induce Biologics Inc was founded in 2008 to develop and
commercialize technologies invented at the University of Toronto.
Induce Biologics' goal is to utilize these technologies along with
others being developed internally to create cost effective growth
factor containing bone grafts for mammalian skeletal regeneration.
For further information: Media Contact: Thomas Wellner, President
and CEO, Therapure Biopharma Inc., +1-905-286-6204,
ots Originaltext: Therapure Biopharma Inc
Im Internet recherchierbar: http://www.presseportal.ch
For further information: Media Contact: Thomas Wellner, President and
CEO, Therapure Biopharma Inc., +1-905-286-6204, firstname.lastname@example.org/